Possible role of autoimmunity in patients with premature ovarian insufficiency

International Journal of Fertility and Sterility

Volumn 7, Issue 4, 2014, Pages 281-290

  Pogačnik, Renata Košir ^a   Vrtovec, Helena Meden ^a   Vizjak, Alenka ^b   Levičnik, Alenka Uršula ^a   Slabe, Nina ^a   Ihan, Alojz ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Autoantibody; Cell Immunity; Premature Ovarian Insufficiency; T Lymphocyte; Thyroid Stimulating Antibody

Indexed keywords

AUTOANTIBODY; CORTICOTROPIN; FRAGILE X MENTAL RETARDATION PROTEIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

ADRENAL INSUFFICIENCY; ADULT; AMENORRHEA; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GENETIC SCREENING; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; HYPERGONADOTROPIC HYPOGONADISM; IMMUNOFLUORESCENCE; KARYOTYPING; LUTEINIZING HORMONE BLOOD LEVEL; PREMATURE OVARIAN FAILURE; PROLACTIN BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THYROTROPIN BLOOD LEVEL; YOUNG ADULT;

EID: 84891104745     PISSN: 2008076X     EISSN: 20080778     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Conway GS. Premature ovarian failure. Br Med Bull. 2000; 56(3): 643-649.
2. Goswami D, Conway GS. Premature ovarian failure. Horm Res. 2007; 68(4): 196-202.
3. Anasti JN. Premature ovarian failure: an update. Fertil Steril. 1998; 70(1): 1-15.
4. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterisation of idiopathic premature ovarian failure. Fertil Steril. 1996; 65(2): 337-341.
5. Husebye ES, Løvås K. Immunology of Addison's disease and premature ovarian failure. Endocrinol Metab Clin North Am. 2009; 38(2): 389-405.
6. Poppe K, Velkeniers B. Female infertility and the thyroid. Best Pract Res Clin Endocrinol Metab. 2004; 18(2): 153-165.
7. Edassery SL, Shatavi SV, Kunkel JP, Hauer C, Brucker C, Penumatsa K, et al. Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. Fertil Steril. 2010; 94(7): 2636-2641.
8. Welt CK. Autoimmune oophoritis in the adolescent. Ann NY Acad Sci. 2008; 1135: 118-122.
9. Ashrafi M, Fallahian M, Eshrati B, Salman Yazdi R. The presence of anti thyroid and anti ovarian auto-antibodies in familial POF. Int J Fertil Steril. 2008; 1(4): 171-174.
10. Irvine WJ, Barnes EW. Addison's disease, ovarian failure and hypoparathyroidism. Clin Endocrinol Metab.1975; 4(2): 379-434.
11. Turkington RW, Lebovitz HE. Extra-adrenal endocrine deficiencies in Addison's disease. Am J Med. 1967; 43(4): 499-507.
12. rd ed. Philadelphia: WB Saunders; 1995; 3013-3024.
13. Blizzard RM, Chee D, Davies W. The incidence of adrenal and other antibodies in sera of patients with idiopathic adrenal insufficiency (Addison's disease). Clin Exp Immunol. 1967; 2(1): 19-30.
14. Irvine WJ, Chan MM, Scarth L, Kolb FO, Hartog M, Bayliss RI, et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet. 1968; 2(7574): 883-887.
15. Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004; 10(2): 163-175.
16. Morita Y, Tilly JL. Oocyte apoptosis: like sand through an hourglass. Dev Biol. 1999; 213(1): 1-17.
17. Zuckerman S. The number of oocytes in the mature ovary. Recent Prog Horm Res. 1951; 6(1): 63-108.
18. Byskof AG, Faddy MJ, Lemmen JG, Andersen CY. Eggs forever?. Differentiation. 2005; 73(9-10): 438-446.
19. Liu Y, Wu C, Lyu Q, Yang D, Albertini DF, Keefe DL, et al. Germline stem cells and neo-oogenesis in the adult human ovary. Dev Biol. 2007; 306(1): 112-120.
20. Bukovsky A, Virant-Klun I, Svetlikova M, Willson I. Ovarian germ cells. Methods Enyzmol. 2006; 419: 208-258.
21. Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol. 1986; 68(6): 850-854.
22. Groselj-Grenc M, Ihan A, Derganc M. Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm. 2008; 2008: 202646.
23. Lahita RG. Predisposing factors to autoimmune disease. Int J Fertil Womens Med. 1997; 42(2): 115-119.
24. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev. 1997; 18(1): 107-134.
25. Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal autoantibodies detected asymptomatic autoimmune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod. 2002; 17(8): 2096-2100.
26. Brozzetti A, Marzotti S, La Torre D, Bacosi ML, Morelli S, Bini V, et al. Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response. Eur J Endocrinol. 2010; 163(2): 309-317.
27. Dragojevic-Dikic S, Marisavljevic D, Mitrovic A, Dikic S, Jovanovic T, Jankovic-Raznatovic S. An immunological insight into premature ovarian failure (POF). Autoimmun Rev. 2010; 9(11): 771-774.
28. Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol. 1993; 39(1): 35-43.
29. Goswami R, Marwaha RK, Goswami D, Gupta N, Ray D, Tomar N, et al. Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab. 2006; 91(11): 4256-4259.
30. Irvine WJ. Premature menopause in autoimmune disease. Lancet. 1969; 1(7588): 264.
31. Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet. 1966; 2(7457): 264-265.
32. Gleicher N, Weghofer A, Oktay K, Barad D. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)?. Hum Reprod. 2009; 24(10): 2395-2400.
33. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005; 11(4): 391-410.
34. Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med. 2002; 11(7): 585-599.
35. Yan G, Schoenfeld D, Penney C, Hurxthal K, Taylor A, Faustman D. Identification of premature ovarian failure patients with underlying autoimmunity. J Womens Health Gend Based Med. 2000; 9(3): 275-287.
36. Monnier-Barbarino P, Forges T, Faure GC, Béné MC. Gonadal antibodies interfering with female reproduction. Best Pract Res Clin Endocrinol Metab. 2005; 19(1): 135-148.
37. Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed towards ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol. 1985; 9(1): 23-24.
38. Gleicher N, Weghofer A, Barad D. Female infertility due to abnormal autoimmunity: frequently overlooked and greatly underappreciated. Part II. Expert Rev Obstet Gynecol. 2007; 2(4): 465-475.
39. Gleicher N, Weghofer A, Barad D. Female infertility due to abnormal autoimmunity: frequently overlooked and greatly underappreciated. Part I. Expert Rev Obstet Gynecol. 2007; 2(4): 453-464.
40. Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol. 1993; 39(1): 35-43.
41. Wheatcroft NJ, Toogood AA, Li TC, Cooke ID, Weetman AP. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol. 1994; 96(1): 122-128.
42. Luborsky JL, Visintin I, Boyers S, Asari T, Caldwell B, DeCherney A. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab. 1990; 70(1): 69-75.
43. Moncayo H, Moncayo R, Benz R, Wolf A, Lauritzen C. Ovarian failure and autoimmunity: detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. J Clin Invest. 1989; 84(6): 1857-1865.
44. Sotsion F, Bottazzo GF, Doniach D. Immunoofluorescence studies on antibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol. 1980; 39(1): 97-111.
45. Horejsi J, Martinek J, Novakova D, Madar J, Brandejska M. Autoimmune antiovarian antibodies and their impact on the success of an IVF/ET program. Ann N Y Acad Sci. 2000; 900: 351-356.
46. Meyer WR, Lavy G, DeCherney AH, Visintin I, Economy K, Luborsky JL. Evidence of gonadal and gonadotropin antibodies in woman with suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol. 1990; 75(5): 795-799.
47. Luborsky J, Pong R. Pregnancy outcome and ovarian antibodies in infertility patients undergoing controlled ovarian hyperstimulation. Am J Reprod Immunol. 2000; 44(5): 261-265.
48. Luborsky JL, Thiruppathi P, Rivany B, Roussev R, Coulam C, Radwanska E. Evidence for different etiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles of presence of ovarian autoantibodies. Hum Reprod. 2002; 17(10): 2641-2649.
49. Mignot MH, Drexhage HA, Kleingeld M, Van de, Plassche-Boers EM, Rao BR, Schoemaker J. Premature ovarian failure. II: Considerations of cellular immunity defects. Eur J Obstet Gynecol Reprod Biol. 1989; 30(1): 67-72.
50. Miyake T, Sato Y, Takeuchi S. Implications of circulating autoantibodies and peripheral blood lymphocyte subset for the genesis of premature ovarian failure. J Reprod Immunol. 1987; 12(3): 163-171.
51. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995; 155(3): 1151-1164.
52. Long SA, Buckner JH. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J Immunol. 2011; 187(5): 2061-2066.
53. Chernysmov VP, Radysh TV, Gura IV, Tatarchuk TP, Khominskaya ZB. Immune disorders in women with premature ovarian failure in initial period. Am J Reprod Immunol. 2001; 46(3): 220-225.
54. Ho PC, Tang GW, Lawton JW. Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after estrogen replacement. Hum Reprod. 1993; 8(5): 714-716.
55. Van Houten EL, Themmen AP, Visser JA. Anti-Müllerian hormone (AMH): regulator and marker of ovarian function. Ann Endocrinol (Paris). 2010; 71(3): 191-197.
56. Baird DD, Steiner AZ. Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability. Am J Epidemiol. 2012; 175(4): 245-249.
57. Van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum anti müllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005; 83(4): 979-987.
58. Domingues TS, Rocha AM, Serafini PC. Tests for ovarian reserve: reliability and utility. Curr Opin Obstet Gynecol. 2010; 22(4): 271-276.
59. Meden-Vrtovec H, Osredkar J. Anti-Müllerian hormone-a predictor of ovarian reserve. Zdrav Vestn. 2010; 79(6): 507-511.
60. Nelson SM, Anderson RA, Broekmans FJ, Raine-Fenning N, Fleming R, La Marca A. Anti-Müllerian hormone: clairvoyance or crystal clear?. Hum Reprod. 2012; 27(3): 631-636.
61. Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booij MJ, Hoek A, Beerendonk CC, et al. Anti-Müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009; 94(3): 786-792.